STEGLUJAN 15-100 MG TABLET

ertugliflozin and sitagliptin
$17.5370per EA

Strength

15; 100 mg/1; mg/1

NDC

00006536803

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA209805

On Market Since

12/19/2017

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price History

1W

0.0%

1M

-0.3%

3M

-0.4%

6M

-1.0%

1Y

-1.0%

3Y

-0.5%

5Y

-0.3%

All

-0.2%